Aker BioMarine
AKBM | OL
Overview
Corporate Details
- ISIN(s):
- NO0010886625 (+1 more)
- LEI:
- 549300V34T6VWDSYWE64
- Country:
- Norway
- Address:
- Oksenøyveien 10, 1366 Lysaker
- Website:
- https://www.akerbiomarine.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Aker BioMarine was created because of our strong belief in the positive health effects of krill. More than a decade later, our business continues to grow because we take care of the ecosystem we harvest in. To us, it makes no sense to take something out of the ocean to improve our health, if it simultaneously compromises the health of the ocean. Ensuring the well-being of the krill biomass and contributing towards a thriving Antarctic ecosystem are among our core priorities. The unique phospholipid-bound omega-3s in krill can help reduce the risk of several lifestyle diseases, including heart and brain-related issues. Aker BioMarine has taken on a global challenge to raise awareness about the importance of omega-3s. In 2020, 1,6 billion doses of Superba Krill were sold worldwide, improving the health of millions of people.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-02 12:45 |
Directors' Dealings
Mandatory notification of trade
|
English | 129.3 KB | |
| 2025-05-02 12:45 |
Directors' Dealings
Mandatory notification of trade
|
English | 1.4 KB | |
| 2025-04-30 05:00 |
Earnings Release
First quarter 2025 results for Aker BioMarine
|
English | 1.4 MB | |
| 2025-04-30 05:00 |
Earnings Release
First quarter 2025 results for Aker BioMarine
|
English | 4.3 KB | |
| 2025-04-28 16:00 |
Regulatory News Service
Aker BioMarine ASA – Invitation to presentation of the first quarter 2025 resul…
|
English | 1.8 KB | |
| 2025-04-26 07:05 |
Declaration of Voting Results & Voting Rights Announcements
Aker BioMarine ASA – Minutes of Annual General Meeting
|
Norwegian | 223.3 KB | |
| 2025-04-26 07:05 |
Declaration of Voting Results & Voting Rights Announcements
Aker BioMarine ASA – Minutes of Annual General Meeting
|
Norwegian | 751.1 KB | |
| 2025-04-26 07:05 |
Declaration of Voting Results & Voting Rights Announcements
Aker BioMarine ASA – Minutes of Annual General Meeting
|
English | 1.5 KB | |
| 2025-04-02 06:15 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 206.2 KB | |
| 2025-04-02 06:15 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 112.5 KB | |
| 2025-04-02 06:15 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 2.0 MB | |
| 2025-04-02 06:15 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 320.9 KB | |
| 2025-04-02 06:15 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting (Correction)
|
English | 2.6 KB | |
| 2025-03-31 06:00 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting
|
Norwegian | 191.6 KB | |
| 2025-03-31 06:00 |
Regulatory News Service
Aker BioMarine ASA – Notice of Annual General Meeting
|
English | 112.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO | |
|
Onxeo | France | ALONX | |
|
OPKO Health Inc. | Israel | OPK | |
|
Oramed Pharmaceuticals Inc. | Israel | ORMP | |
|
Oryzon Genomics S.A. | Spain | ORY |